None of this would have been a problem if the cannabis industry, like every other legal business in the U.S., had access to banking.

MedMen will go down in the annals as a symbol of the early days of the legal-weed industry: a meteoric rise and a spectacular crash.

There’s a frankness that was fairly unusual even at in-person trade shows that are now canceled or delayed as we all shelter in place.

Given the economic pressures that governments face, the push to legalize pot could end up resembling the end of prohibition in more ways than one.

The dual nature of cannabis—it’s both a “vice” and a health elixir, and sometimes both at once—makes it hard to regulate.

The Food and Drug Administration isn’t effing around when it comes to cracking down on companies selling supposed cures for Covid-19.

Some pot advocates and peddlers of elixirs now declare that their products can alleviate the symptoms of Covid-19, or even cure it. 

Celebrity investors. Headline-grabbing IPOs. New tax revenues. Is the cannabis industry getting high on its own supply?